Ranbaxy receives final USFDA approval for Glycopyrolate
BS reporter / Mumbai Aug 24, 2009, 12:40 IST
Ranbaxy Laboratories today announced that it had received final approval from the US Food and Drug Administration (USFDA) to market and manufacture Glycopyrolate tablets.
The drug is indicated for use as adjunctive therapy in the treatment of peptic ulcer.